Early Serum Proteomic Diagnosis and Classification of Preeclampsia Preeclampsia accounts for 15% of all maternal deaths in pregnancy, complicates over 160,000 pregnancies in US, and costs our health care system 7 billion dollars a year. Additionally, preeclampsia has dire consequences for the fetus including death and long term disability from attendant intrauterine growth retriction and prematurity. Preeclampsia has increased over 40% over the last decade (WHO) and disproportionately affects minority groups. Despite significant reasearch effort there is no early test for preeclampsia or effective treatment: the complex spectrum of disease and the elusive pathologic factors released by the placenta that damage the maternal vascular system have remained significant obstacles to these goals. Understanding the status of the maternal serum proteome and how it mediates preeclampsia is critical for early diagnosis and eventual treatment. We plan to collect maternal serum from preeclamptic mothers at three time points; at labor, at onset and prospectively at 15-20 weeks gestation. Proteins and peptides present in preeclamptic serum will be compared to normal controls. Discovering and evaluating a large number of peptides requires the use of a high throughput mass spectrometer and a neural-network bioinformatic algorithm. Discriminating proteins and peptides will be correlated with clinical outcome, presentation and severity of disease. Through this method we hope to develop an early serum test for preeclampsia that stratifies patients according to potential severity and treatment response. This """"""""biosignature"""""""" can be monitored in real-time for treatment efficacy. Constituent proteins and peptides discriminating disease, outcome and response will be identified to determine those serum factors responsible for transmitting the placental disease to the mother.

National Institute of Health (NIH)
National Center for Research Resources (NCRR)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZRR1-RI-1 (01))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Hawaii
Obstetrics & Gynecology
Schools of Medicine
United States
Zip Code
Riangwiwat, Tanawan; Kohorn, Lindsay B; Chow, Dominic C et al. (2016) CD4/CD8 Ratio Predicts Peripheral Fat in HIV-Infected Population. J Acquir Immune Defic Syndr 72:e17-9
Wright, Tricia E; Schuetter, Renee; Tellei, Jacqueline et al. (2015) Methamphetamines and pregnancy outcomes. J Addict Med 9:111-7
Horton, J S; Yamamoto, S Y; Bryant-Greenwood, G D (2012) Relaxin augments the inflammatory IL6 response in the choriodecidua. Placenta 33:399-407
Burlingame, J; Horiuchi, B; Ohana, P et al. (2012) The contribution of heart disease to pregnancy-related mortality according to the pregnancy mortality surveillance system. J Perinatol 32:163-9
Hiraoka, Mark; Urschitz, Johann; Sultan, Omar et al. (2011) A polymorphism in the retinol binding protein 4 gene is not associated with gestational diabetes mellitus in several different ethnic groups. Hawaii Med J 70:164-7
Horton, J S; Yamamoto, S Y; Bryant-Greenwood, G D (2011) Relaxin modulates proinflammatory cytokine secretion from human decidual macrophages. Biol Reprod 85:788-97
Wright, T E; Milam, K A; Rougee, L et al. (2011) Agreement of umbilical cord drug and cotinine levels with maternal self-report of drug use and smoking during pregnancy. J Perinatol 31:324-9
Kendal-Wright, C E; Hubbard, D; Gowin-Brown, J et al. (2010) Stretch and inflammation-induced Pre-B cell colony-enhancing factor (PBEF/Visfatin) and Interleukin-8 in amniotic epithelial cells. Placenta 31:665-74
Urschitz, Johann; Kawasumi, Miyuri; Owens, Jesse et al. (2010) Helper-independent piggyBac plasmids for gene delivery approaches: strategies for avoiding potential genotoxic effects. Proc Natl Acad Sci U S A 107:8117-22
Wright, Tricia E; Tam, Elizabeth (2010) Disparate rates of persistent smoking and drug use during pregnancy of women of Hawaiian ancestry. Ethn Dis 20:S1-215-8

Showing the most recent 10 out of 59 publications